两倍做多纳斯达克生物科技指数ETF-ProShare
开盘价
市值
最高价
最低价
收盘价
成交量
市盈率
股息率
两倍做多纳斯达克生物科技指数ETF-ProShare简介
ProShares Trust-ProShares超纳斯达克生物技术是一家由ProShare Advisors LLC推出和管理的交易所交易基金。它投资于美国的公开股票市场。它通过衍生品投资于医疗保健、制药、生物技术和生命科学领域运营的公司的股票。它使用掉期等衍生品来创建投资组合。该基金投资于不同市值公司的成长型和价值型股票。该基金寻求通过使用完全复制技术，跟踪纳斯达克生物技术指数的每日表现2倍。ProShares Trust-ProShares超纳斯达克生物科技公司成立于2010年4月7日，注册地为美国。
交易GPT
如何购买 两倍做多纳斯达克生物科技指数ETF-ProShare (BIB)
登录
1分钟开户
仅需1分钟即可完成账户申请和验证。整个过程完全自助，支持 RockFlow App 和网页端操作。
充值资金
账户验证完成后，您可以使用首选的支付方式向账户充值。
购买 BIB
通过 RockFlow App 或网页端搜索 BIB，输入您想要投资的金额，然后点击确认即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.